Articles

  • 1 week ago | driverlessreport.com | Kevin Dennehy

    Autonomous truck developer Kodiak Robotics announced this week that it will go public via a merger with Ares Acquisition Corporation II AACT 0.09%↑, a special purpose acquisition company (SPAC). The deal values Kodiak at approximately $2.5 billion and is expected to close in the second half of 2025. The transaction includes more than $110 million in committed capital from institutional investors, including Ares Management, Soros Fund Management, and ARK Investment Management.

  • 1 week ago | driverlessreport.com | Kevin Dennehy

    Connected and Autonomous Vehicles:😮 Musk’s DOGE Purges NHTSA Experts On Self-Driving Risks, Guess Who Benefits? “News about recent firings by Elon Musk’s Department of Government Efficiency (DOGE) has raised concerns about potential conflicts of interest for the Tesla TSLA -0.59%↓ CEO.”🤔 Qualcomm’s Connected Car Moment Arrives. “McKinsey should pay a visit to Qualcomm QCOM 1.05%↑.

  • 1 week ago | locationbusinessnews.com | Kevin Dennehy

    TomTom [TOM2] kicked off 2025 with a modest revenue increase and notable progress across its Automotive and Enterprise segments, the company reported this week. CEO Harold Goddijn emphasized the momentum behind the company’s mapping investments, which are fueling growth in sectors such as fleet management and geospatial analytics. “We had a healthy start to the year,” Goddijn said in a statement, highlighting TomTom Orbis Maps’ expanding capabilities.

  • 1 week ago | phys.org | Kevin Dennehy

    Bacteriophages, or phages, viruses that selectively target and infect bacteria, have drawn growing attention for their potential use in a host of biotechnological processes to benefit humankind, from diagnosing contamination in consumer products to treating antibiotic-resistant infections.

  • 1 week ago | news.yale.edu | Kevin Dennehy

    Bacteriophages, or phages, viruses that selectively target and infect bacteria, have drawn growing attention for their potential use in a host of biotechnological processes to benefit humankind, from diagnosing contamination in consumer products to treating antibiotic-resistant infections.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
273
Tweets
547
DMs Open
Yes
Kevin Dennehy
Kevin Dennehy @KevinDennehy
20 Dec 24

https://t.co/LZJLer6p2R

Kevin Dennehy
Kevin Dennehy @KevinDennehy
29 Oct 24

Great event with @BurtTalksSports today at the @EagleTrib. Great to get Bill's insight on 40 years of Boston area sports! https://t.co/oesUzYbQv9

Kevin Dennehy
Kevin Dennehy @KevinDennehy
27 Oct 24

RT @mappedin: Did you know the average person spends 87% of their time indoors? That’s why we’re making it easier for anyone to map their s…